You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Baxter
AstraZeneca
Colorcon
Merck

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

RESECTISOL IN PLASTIC CONTAINER Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Resectisol In Plastic Container, and when can generic versions of Resectisol In Plastic Container launch?

Resectisol In Plastic Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in RESECTISOL IN PLASTIC CONTAINER is mannitol. There are eighteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the mannitol profile page.

Drug patent expirations by year for RESECTISOL IN PLASTIC CONTAINER
Recent Clinical Trials for RESECTISOL IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Neurological Disorders and Stroke (NINDS)Phase 1/Phase 2
National Cancer Institute (NCI)Phase 1/Phase 2
OHSU Knight Cancer InstitutePhase 1/Phase 2

See all RESECTISOL IN PLASTIC CONTAINER clinical trials

Pharmacology for RESECTISOL IN PLASTIC CONTAINER
Drug ClassOsmotic Diuretic
Mechanism of ActionOsmotic Activity
Physiological EffectIncreased Diuresis

US Patents and Regulatory Information for RESECTISOL IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun RESECTISOL IN PLASTIC CONTAINER mannitol SOLUTION;IRRIGATION 016772-002 Approved Prior to Jan 1, 1982 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Merck
Express Scripts
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.